The FDA today issued a notice informing customers of updated instructions for the Johnson & Johnson Abiomed Impella RP heart ...

By analyzing E. coli protein levels, scientists found a surplus of membrane shuttle proteins that may play a role in antibiotic resistance.

We recently published a list of 10 Unstoppable Stocks to Buy in 2025. In this article, we are going to take a look at where BridgeBio Pharma, Inc. (NASDAQ:BBIO) stands against other unstoppable ...

TD Cowen analyst Tyler Van Buren has maintained their bullish stance on BBIO stock, giving a Buy rating on January 14. Tyler Van Buren has given his Buy rating due to a combination of factors ...

DORADO, PUERTO RICO / ACCESS Newswire / January 29, 2025 / Pharma-Bio Serv, Inc. ('Pharma-Bio Serv' or the 'Company') (OTCQB:PBSV), a regulatory affairs, quality, compliance, project management and ...

Brian Feth, Jonathan Grinstein, PhD, Beth Willers, and Laks Pernenkil go behind the headlines to discuss major news announcements made during the JP Morgan Healthcare Conference, a wave of new ...

and SHANGHAI, Jan. 21, 2025 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP) a clinical-stage company dedicated to accelerating the global development of ...

The innovative MicroCNX® Nano Series connectors help maintain sterility in CGT processes using 1/8- or 1/16-inch tubing and launches today at the Advanced Therapies Week meeting in Dallas. “Cell ...

Will 2025 herald a sudden turnaround for biopharma? Unlikely, but continued recovery is likely with some strong growth in therapy areas including cancer, diabetes and – inevitably – obesity. Four of ...

A penis pump can help treat erectile dysfunction (ED) by using negative air pressure to increase blood flow in the penis and create an erection. Also known as a vacuum pump or vacuum erection device, ...

As the J.P. Morgan Healthcare Conference started in San Francisco on Monday, AbbVie linked up with Simcere with a $1 billion deal for the Chinese biopharma's phase 1 T-cell engager. Later during ...